Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) is a common, treatable sleep disorder in which the muscles around the throat relax and the upper airway repeatedly narrows or collapses during sleep, briefly blocking breathing dozens or even hundreds of times a night. Each pause lowers blood oxygen and jolts the brain partly awake to reopen the airway, so sleep is fragmented even when a person believes they slept through the night — and over time the condition is closely tied to daytime sleepiness, high blood pressure, and heart disease.

What is obstructive sleep apnea?

During normal sleep, the muscles of the throat relax but the upper airway stays open enough to breathe freely. In OSA, the soft tissues at the back of the throat — the soft palate, uvula, tongue base, and walls of the pharynx — relax too much and the airway narrows or closes. A complete blockage lasting at least 10 seconds is called an apnea; a partial blockage that reduces airflow and is accompanied by an oxygen drop or a brief awakening (arousal) is called a hypopnea (NIH/StatPearls; American Academy of Sleep Medicine, AASM).

Each event causes a fall in blood oxygen and a surge of effort to breathe against the closed airway. The brain responds with a brief arousal that reopens the airway, often with a gasp, snort, or choke — and then the cycle repeats. Because these arousals are usually too short to be remembered, many people have no idea their sleep is being interrupted; the chief clue is often a bed partner reporting loud snoring and pauses in breathing.

OSA is the most common form of sleep-disordered breathing. Its medical name is obstructive sleep apnea, and the ICD-10 code most often used is G47.33 (obstructive sleep apnea). It is distinct from central sleep apnea, in which the brain intermittently fails to signal the breathing muscles (so there is no airway obstruction and often no snoring); some people have a mix of both, called complex or mixed sleep apnea.

OSA is widespread. Population studies estimate that a substantial share of middle-aged and older adults have at least mild OSA, and prevalence is markedly higher in men, in people with obesity, and with advancing age (NIH/StatPearls). Many cases remain undiagnosed because the symptoms develop gradually and overlap with ordinary fatigue.

What causes obstructive sleep apnea, and who is at risk?

OSA is fundamentally an anatomical and neuromuscular problem: the airway is either structurally smaller, more prone to collapse, or insufficiently supported by muscle tone during sleep. Several factors push the airway toward collapse:

• Excess soft tissue and fat around the neck and throat, which crowd the airway.
• Reduced muscle tone during sleep, especially during REM sleep and after alcohol or sedatives.
• Craniofacial and airway anatomy — a small or set-back jaw (retrognathia), large tongue, enlarged tonsils or adenoids, a long soft palate, or nasal obstruction.

Major risk factors

Well-established risk factors recognized across sleep-medicine guidelines include (NIH/StatPearls; AASM):

• Obesity, particularly central obesity and increased neck circumference — the single most important modifiable risk factor. Weight gain worsens OSA, and weight loss improves it.
• Male sex. Men are diagnosed considerably more often than women, though the gap narrows after menopause, when women's risk rises.
• Older age. Airway tissues lose tone with age.
• Family history and inherited craniofacial features.
• Enlarged tonsils or adenoids — the leading cause in children.
• Menopause, due to loss of protective hormonal effects on airway muscle tone.
• Smoking, which inflames and narrows the upper airway.
• Alcohol and sedative or opioid use, which relax airway muscles and blunt the arousal response.
• Nasal congestion from allergies or structural problems.
• Certain medical conditions, including hypothyroidism, acromegaly, polycystic ovary syndrome (PCOS), and fluid-retaining states such as heart failure and kidney disease.

OSA is also bidirectionally linked with cardiovascular and metabolic disease: it is highly prevalent among people with resistant hypertension, atrial fibrillation, heart failure, stroke, and type 2 diabetes, and it can worsen these conditions in turn (American Heart Association scientific statement on OSA and cardiovascular disease, *Circulation*).

What are the symptoms of obstructive sleep apnea?

Symptoms span both the night and the day, and a bed partner often notices the nighttime signs first.

Nighttime symptoms:

• Loud, chronic snoring, often punctuated by silent pauses.
• Witnessed pauses in breathing, frequently ending in a gasp, snort, or choking sound.
• Waking suddenly short of breath or with a sensation of choking.
• Restless sleep, frequent awakenings, and nighttime sweating.
• Frequent trips to the bathroom at night (nocturia).

Daytime symptoms:

• Excessive daytime sleepiness — feeling unrefreshed despite a full night in bed, and dozing off while reading, watching TV, or even driving.
• Morning headaches and a dry or sore throat on waking.
• Difficulty concentrating, memory problems, and irritability or low mood.
• Reduced libido or erectile dysfunction.

It is important to know that not everyone with OSA snores loudly, and many people — especially women — present with less classic symptoms such as fatigue, insomnia, anxiety, or depression rather than obvious sleepiness. This is one reason OSA is under-recognized in women.

How is obstructive sleep apnea diagnosed?

Diagnosis begins with a clinical evaluation of symptoms and risk factors, often aided by validated questionnaires such as STOP-Bang (snoring, tiredness, observed apneas, blood pressure, BMI, age, neck circumference, gender) or the Epworth Sleepiness Scale, which measures daytime sleepiness. These tools screen for risk but cannot confirm the diagnosis on their own (AASM Clinical Practice Guideline for Diagnostic Testing for Adult OSA, 2017).

A diagnosis requires an objective sleep study, which measures the apnea-hypopnea index (AHI) — the average number of apneas plus hypopneas per hour of sleep.

• In-laboratory polysomnography (PSG) is the reference standard. Performed overnight in a sleep center, it records brain waves (EEG), eye and muscle movements, airflow, breathing effort, blood oxygen, heart rhythm, and body position. It is preferred for people with significant heart or lung disease, suspected central sleep apnea, or other complicating conditions.
• Home sleep apnea testing (HSAT) uses a simpler portable device worn at home and is an appropriate, validated option for adults with a high pretest probability of moderate-to-severe OSA and no major comorbidities. Because HSAT can underestimate severity, a negative or inconclusive home test in a symptomatic patient is generally followed by in-lab PSG (AASM 2017 guideline).

Severity criteria and thresholds

OSA is confirmed and graded by the AHI, using the AASM and International Classification of Sleep Disorders (ICSD-3) framework:

• An AHI of 5 or more events per hour combined with symptoms (such as sleepiness, snoring, or gasping) or a relevant comorbidity (such as hypertension), or an AHI of 15 or more events per hour regardless of symptoms, meets the criteria for OSA.
• Mild OSA: AHI 5 to under 15.
• Moderate OSA: AHI 15 to 30.
• Severe OSA: AHI greater than 30.

Reports may also note the oxygen desaturation index (ODI) and the lowest oxygen saturation reached overnight, which help describe how much the blood oxygen drops. Definitions of a hypopnea have varied across AASM scoring rules over the years (the airflow-reduction and oxygen-desaturation thresholds differ), which is one reason two tests can report somewhat different AHI values.

How is obstructive sleep apnea treated?

Treatment is individualized to severity, anatomy, and patient preference, and usually combines behavioral changes with a device or, in selected cases, medication or surgery. The goals are to keep the airway open during sleep, normalize the AHI and oxygen levels, relieve symptoms, and reduce cardiovascular risk.

Lifestyle and behavioral measures (first steps for everyone)

These are recommended for all patients and may be sufficient on their own in mild cases:

• Weight loss if overweight, which can substantially lower the AHI and is among the most effective long-term measures.
• Positional therapy for people whose apnea is worse when sleeping on their back — using devices or techniques that encourage side-sleeping.
• Avoiding alcohol and sedatives, especially in the hours before bed.
• Smoking cessation and treating nasal congestion (for example, allergy management).
• Consistent sleep schedule and adequate sleep duration.

Positive airway pressure (the mainstay device therapy)

Continuous positive airway pressure (CPAP) is the first-line and most effective treatment for moderate-to-severe OSA (AASM). A bedside machine delivers a gentle, steady stream of air through a mask, acting as a pneumatic splint that holds the airway open. Variations include auto-adjusting PAP (APAP), which varies pressure through the night, and bilevel PAP (BiPAP), which uses different pressures for breathing in and out and can help people who struggle with standard CPAP. When used consistently, PAP reliably reduces the AHI, daytime sleepiness, and blood pressure; the main limitation is adherence, since some people find the mask uncomfortable.

Oral appliances

A custom-fitted mandibular advancement device, made by a dentist trained in sleep medicine, holds the lower jaw and tongue slightly forward to keep the airway open. Oral appliance therapy is a recommended alternative for adults with mild-to-moderate OSA, and for those with more severe disease who cannot tolerate PAP (AASM/American Academy of Dental Sleep Medicine).

Prescription medication

For the first time, a medication is FDA-approved specifically for OSA. In December 2024, the FDA approved tirzepatide (Zepbound) — a GLP-1/GIP receptor agonist (the same class as drugs used for weight management) — for moderate-to-severe OSA in adults with obesity, to be used alongside a reduced-calorie diet and increased physical activity. Approval was based on the phase 3 SURMOUNT-OSA trial, in which tirzepatide meaningfully reduced the AHI; nearly half of participants reached a threshold consistent with disease remission or no symptoms (Eli Lilly; AASM). It works indirectly, primarily through weight loss, and is an option for selected patients rather than a universal replacement for PAP.

There is no over-the-counter medication that treats OSA itself. Nasal strips, saline, or decongestants may ease nasal breathing but do not correct airway collapse, and sedating sleep aids can worsen apnea. Treating contributing conditions — for example, thyroid hormone replacement for hypothyroidism — is also part of care.

Surgical and implant options

For patients who cannot tolerate PAP or have correctable anatomy, options include hypoglossal nerve stimulation — an implanted device (such as Inspire) that activates the tongue muscles with each breath to keep the airway open. It is not a first-line therapy; it is reserved for select adults with moderate-to-severe OSA who have not succeeded with PAP, typically within a defined body-mass-index range and after a procedure confirms a suitable airway collapse pattern. Other surgical approaches include tonsillectomy/adenoidectomy (the first-line treatment in children), procedures to reduce or reposition soft-palate and throat tissue, and jaw-advancement surgery in carefully selected cases.

Can obstructive sleep apnea be prevented or managed long-term?

OSA cannot always be prevented — anatomy and age are not modifiable — but its risk and severity can often be reduced, and it can be managed effectively over the long term. Maintaining a healthy weight is the most impactful preventive and management strategy; limiting alcohol and sedatives, not smoking, and treating nasal and allergic problems also help.

For most people, OSA is a chronic condition that requires ongoing management rather than a one-time cure. Long-term success depends heavily on adherence — for example, using PAP nightly or wearing an oral appliance consistently. Sleep clinicians monitor therapy over time using device data, repeat questionnaires, and sometimes follow-up sleep studies, and they adjust the treatment when weight, anatomy, or symptoms change. Because OSA so often travels with high blood pressure, diabetes, and heart rhythm problems, coordinated care that addresses these related conditions is part of good long-term management.

When should you see a doctor?

It is worth talking to a clinician — and asking about a sleep evaluation — if you or a bed partner notice:

• Loud, habitual snoring with pauses in breathing, gasping, or choking during sleep.
• Excessive daytime sleepiness, especially falling asleep while driving, working, or in conversation.
• Waking unrefreshed, with morning headaches or a dry throat, on most days.

Seek prompt medical attention for red-flag features, including falling asleep at the wheel or near-miss drowsy-driving episodes, waking gasping for air or with chest pain or palpitations, or new or hard-to-control high blood pressure, an irregular heartbeat such as atrial fibrillation, or symptoms after a stroke or heart event — situations in which untreated OSA can be especially dangerous. Anyone whose sleepiness threatens safe driving should raise this with a clinician without delay.

What is the outlook for obstructive sleep apnea?

The outlook for treated OSA is generally good. With consistent therapy, most people experience marked improvements in daytime alertness, mood, concentration, and quality of life, and many see better blood pressure control. Effective treatment also reduces the night-to-night oxygen swings and arousals that strain the heart and blood vessels.

Left untreated, moderate-to-severe OSA is associated with higher risks of hypertension, heart attack, stroke, atrial fibrillation, type 2 diabetes, depression, motor-vehicle and workplace accidents, and reduced quality of life (NIH/StatPearls; American Heart Association). The encouraging message is that OSA is highly treatable: the major challenge is recognizing it and sticking with therapy, not a lack of effective options.

Frequently asked questions

Can you have sleep apnea without snoring? Yes. While loud snoring is the classic sign, some people — particularly women and those with central sleep apnea — have little or no snoring and instead notice fatigue, insomnia, morning headaches, or mood changes. A normal report of "no snoring" does not rule out OSA if other symptoms or risk factors are present.

Is CPAP the only treatment, or are there alternatives? CPAP is the most effective and first-line therapy for moderate-to-severe OSA, but it is not the only option. Alternatives include auto-adjusting or bilevel PAP, custom oral appliances (mandibular advancement devices), weight loss, positional therapy, hypoglossal nerve stimulation, and surgery — plus, for adults with obesity and moderate-to-severe OSA, the medication tirzepatide. The best choice depends on severity, anatomy, and personal preference, so it is worth discussing the full menu with a sleep specialist.

Will losing weight cure my sleep apnea? Weight loss can substantially lower the AHI and sometimes resolves mild OSA, and it is one of the most valuable things many people can do. However, not everyone is cured by weight loss alone — anatomy and other factors matter — so therapy should not be stopped without a clinician's guidance and ideally a repeat sleep study to confirm improvement.

Does using a CPAP machine become a lifelong commitment? For most people, OSA is a chronic condition, and CPAP works only while it is being used — symptoms typically return if therapy stops. That said, treatment can change over time: significant weight loss, surgery, or an oral appliance may reduce or end the need for CPAP in some people. Any change should be guided by a clinician and, when appropriate, confirmed with testing.

Is sleep apnea dangerous if I feel fine during the day? Possibly. Some people with significant OSA do not feel noticeably sleepy, yet the repeated drops in oxygen and arousals still strain the cardiovascular system. Because OSA is linked to hypertension, heart rhythm problems, and stroke risk independent of how sleepy a person feels, treatment is often recommended even when daytime symptoms are mild — a decision best made with a clinician based on AHI, oxygen levels, and overall health.